Gene · 9507
Papers2,479
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,221 to 1,240 of 2,479
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Physioxia Has a Beneficial Effect on Cartilage Matrix Production in Interleukin-1 Beta-Inhibited Mesenchymal Stem Cell Chondrogenesis. | Cells | 2019 | 31434236 | PubTator, text mining | PubMed |
| Wnt signaling: a promising target for osteoarthritis therapy. | Cell Commun Signal | 2019 | 31420042 | PubTator, text mining | PubMed |
| Mechanical strain attenuates cytokine-induced ADAMTS9 expression via transient receptor potential vanilloid type 1. | Exp Cell Res | 2019 | 31415758 | PubTator, text mining | PubMed |
| HENA, heterogeneous network-based data set for Alzheimer's disease. | Sci Data | 2019 | 31413325 | PubTator, text mining | PubMed |
| The effect of medium supplementation and serial passaging on the transcriptome of human adipose-derived stromal cells expanded in vitro. | Stem Cell Res Ther | 2019 | 31412930 | PubTator, text mining | PubMed |
| Mechanical loading mediates human nucleus pulposus cell viability and extracellular matrix metabolism by activating of NF-κB. | Exp Ther Med | 2019 | 31410113 | PubTator, text mining | PubMed |
| Network Pharmacology Identifies the Mechanisms of Action of Shaoyao Gancao Decoction in the Treatment of Osteoarthritis. | Med Sci Monit | 2019 | 31409761 | PubTator, text mining | PubMed |
| A gene based approach to test genetic association based on an optimally weighted combination of multiple traits. | PLoS One | 2019 | 31398229 | PubTator, text mining | PubMed |
| Visfatin Connection: Present and Future in Osteoarthritis and Osteoporosis. | J Clin Med | 2019 | 31394795 | PubTator, text mining | PubMed |
| Dexmedetomidine exerts dual effects on human annulus fibrosus chondrocytes depending on the oxidative stress status. | Biosci Rep | 2019 | 31383789 | PubTator, text mining | PubMed |
| LncRNA SNHG1 alleviates IL-1β-induced osteoarthritis by inhibiting miR-16-5p-mediated p38 MAPK and NF-κB signaling pathways. | Biosci Rep | 2019 | 31383786 | PubTator, text mining | PubMed |
| Cartilage and Bone Destruction in Arthritis: Pathogenesis and Treatment Strategy: A Literature Review. | Cells | 2019 | 31382539 | PubTator, text mining | PubMed |
| Dose-Dependent Cannabidiol-Induced Elevation of Intracellular Calcium and Apoptosis in Human Articular Chondrocytes. | J Orthop Res | 2019 | 31378964 | PubTator, text mining | PubMed |
| Gene expression profiles in the dorsal root ganglia of methylmercury-exposed rats. | J Toxicol Sci | 2019 | 31378766 | PubTator, text mining | PubMed |
| Does it go to right address to measure amniotic fluid DAMTS4, ADAMTS5, interleukin-6 and tumor necrosis factor-α without an ELISA assay validation? | J Obstet Gynaecol Res | 2019 | 31373089 | PubTator, text mining | PubMed |
| Desumoylation of aggrecan and collagen II facilitates degradation via aggrecanases in IL-1β-mediated osteoarthritis. | J Pain Res | 2019 | 31372032 | PubTator, text mining | PubMed |
| Saxagliptin suppresses degradation of type II collagen and aggrecan in primary human chondrocytes: a therapeutic implication in osteoarthritis. | Artif Cells Nanomed Biotechnol | 2019 | 31364869 | PubTator, text mining | PubMed |
| TIMP-3 as a therapeutic target for cancer. | Ther Adv Med Oncol | 2019 | 31360238 | PubTator, text mining | PubMed |
| Exosites in Hypervariable Loops of ADAMTS Spacer Domains control Substrate Recognition and Proteolysis. | Sci Rep | 2019 | 31358852 | PubTator, text mining | PubMed |
| Analysis of Endogenous Peptides Released from Osteoarthritic Cartilage Unravels Novel Pathogenic Markers. | Mol Cell Proteomics | 2019 | 31352363 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9507/papers?page=62